Novo Nordisk [pharmaceutical company based in Denmark] is dedicated to the Triple Bottom Line (TBL) approach to sustainability - balancing social and environmental responsibility with economic viability. Their approach began with addressing environmental issues; bioethics, human rights and access to health care in developing countries followed in succession.